about
Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcomaBiomarkers in canine parvovirus enteritis.Clinical, hematological, and biochemical findings in puppies with coronavirus and parvovirus enteritis.First isolation of new canine parvovirus 2a from Tibetan mastiff and global analysis of the full-length VP2 gene of canine parvoviruses 2 in China.Effect of age, gestation and lactation on faecal IgA and calprotectin concentrations in dogs.Effects of body weight on antibody titers against canine parvovirus type 2, canine distemper virus, and canine adenovirus type 1 in vaccinated domestic adult dogs.Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.Enteropathogenic Escherichia coli (EPEC) infection in association with acute gastroenteritis in 7 dogs from Saskatchewan.Fatal pyogranulomatous myocarditis in 10 Boxer puppies.Retrospective characterisation and outcome of canine idiopathic mesenteric purulent lymphadenitis and lymph node abscesses at a teaching hospital from 2005 to 2015.Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings.Amelioration of oxidative stress using N-acetylcysteine in canine parvoviral enteritis.Serum Derived Transfer Factor Stimulates the Innate Immune System to Improve Survival Traits in High Risk Pathogen Scenarios.Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis.Parvoviral myocarditis in a 5-week-old Dachshund.Prospective study of bacteraemia in acute haemorrhagic diarrhoea syndrome in dogs.Expression of chicken parvovirus VP2 in chicken embryo fibroblasts requires codon optimization for production of naked DNA and vectored meleagrid herpesvirus type 1 vaccines.Rottweilers under primary veterinary care in the UK: demography, mortality and disorders.Long-term effects of canine parvovirus infection in dogs.Bioclimatic and altitudinal variables influence the potential distribution of canine parvovirus type 2 worldwide.Molecular characterization of canine parvovirus variants (CPV-2a, CPV-2b, and CPV-2c) based on the VP2 gene in affected domestic dogs in Ecuador.Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.
P2860
Q21131081-CD5E40AA-FFCF-4AA3-B317-882C146ED3DFQ33406366-7E044695-F372-4750-8A15-6A2D001F0EE8Q33411104-EEA8922E-F003-45CD-83EE-699E72A8808FQ34072370-DF7415E1-C637-45BB-B87B-0B26E2384CA4Q35757430-06492BE4-9A6D-4D59-A405-08C13F831CB4Q36286653-C140250B-6206-4AD1-9F1D-A6C01C198833Q37158221-AAFC1A33-95DD-4BBD-B089-B7061178E312Q37170695-F781AB67-D902-4460-9625-F0C70EDFA82AQ37837144-EC70CFC6-2B00-4A05-AE45-134D1ED3458FQ38378361-3DE60534-A408-4CA7-B94C-BCB81377F9CEQ39210837-589BC519-F2AB-4824-AD8F-BC0D418323B9Q40124556-6A8B95C1-BD5F-48C3-A717-D9E1E5EA8478Q40150045-8AC24CF0-2618-46D5-91C9-2CA545C0A15BQ40423406-DA5D6161-BA02-471E-8BCC-E4455AC42320Q41085226-7273AC1B-9087-46A0-AF91-440C68359B38Q41557263-10478C01-3A28-4B19-9D45-51D0A4200A8AQ42254831-659F6DA7-BA77-49DB-BE9A-59AB61FEF2DEQ47148097-5F66017D-ECBE-409E-B02F-9570389349BEQ54254728-EC03A225-D4C5-4C2A-ACBA-F8FEF71DC81DQ55006390-29DAFCB3-5081-4867-9B5E-F3B53B96E0F9Q55089981-24BFDC82-2674-40ED-AACE-A2599AC9A031Q55487393-08A73B10-2352-40EC-A2F8-22B5D1348F88
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Canine parvovirus.
@en
Canine parvovirus.
@nl
type
label
Canine parvovirus.
@en
Canine parvovirus.
@nl
prefLabel
Canine parvovirus.
@en
Canine parvovirus.
@nl
P1476
Canine parvovirus.
@en
P304
P356
10.1016/J.CVSM.2010.07.007
P577
2010-11-01T00:00:00Z